- 80 heart transplants in 2026: A 33% increase from UCSF Health's previous average of 60 annual transplants.
- 31% year-over-year growth: Significant rise in transplant volume due to outsourced organ recovery.
- 24/7 on-demand network: Paragonix Transplant Services provides specialized recovery surgeons, reducing logistical burdens.
Experts would likely conclude that outsourcing organ recovery to specialized networks significantly improves transplant program capacity and efficiency, addressing critical bottlenecks in donor organ logistics while mitigating surgeon burnout.
Outsourcing Organ Recovery: How UCSF Health Reached Record Heart Transplants
SAN FRANCISCO, CA – November 19, 2026 — In the high-stakes world of solid organ transplantation, the limiting factor has rarely been just the availability of donor organs. It is the grueling, unpredictable logistics of retrieving them. When an organ becomes available, a high-stakes countdown begins. Historically, this meant dispatching a highly trained, in-house surgical team on a midnight flight across the country, subjecting them to hours of travel, the complex surgical extraction of a donor heart, and a frantic race back to the home hospital. It is a model that saves lives but routinely burns out the very surgeons required to perform the delicate implantation procedures.
Now, a shift in operational strategy is proving that there is a more resilient way to manage this life-saving supply chain. Today, Paragonix Technologies announced that its clinical services division has propelled UCSF Health to a historic milestone: more than 80 heart transplants completed in 2026. This represents a staggering increase for the institution, which had plateaued at an average of 60 annual adult heart transplants over the past half-decade. The catalyst for this unprecedented growth was not a sudden influx of local donors, but a strategic decision to outsource the heavy lifting of organ recovery to a specialized, third-party network.
Since January, the San Francisco-based medical center has partnered with Paragonix Transplant Services, utilizing the company's 24/7 on-demand network of ACIN-certified recovery surgeons, surgical assistants, and preservationists. By removing the logistical burden from its internal staff, the hospital effectively decoupled its transplant volume from the physical limitations of its own workforce.
The Capacity Conundrum and Surgeon Burnout
For years, hospital administrators have grappled with the structural inefficiencies of transplant medicine. A review of historical data from the Scientific Registry of Transplant Recipients illustrates the bottleneck. In 2022, UCSF completed 56 adult heart transplants. That number crept up to 60 in 2023, 63 in 2024, and 61 in 2025. Pushing past that ceiling required more than just clinical excellence; it demanded a fundamental restructuring of how opportunities were managed.
"Growing a transplant program means being ready to go whenever an organ becomes available, and that takes more capacity than any one team can carry on its own," said Amy Fiedler, MD, Surgical Director of Heart Transplant at UCSF Health. "The Paragonix team works as a true extension of our own transplant teams. We’re all working toward the same goals, and their support across organ offers and procurement gives us the flexibility to respond to more opportunities. That partnership has been an important part of our growth this year."
The partnership highlights a critical assessment of modern healthcare: human capital is finite. When an institution relies on the same specialized surgeons to both procure and implant organs, it inherently limits the number of donor offers it can accept. By utilizing external teams operating out of regional hubs, the hospital preserves its internal surgical talent for the critical implantation phase, mitigating fatigue and drastically reducing the risk of burnout.
Shifting Business Models: From Devices to Turnkey Services
From a business perspective, the evolution of Paragonix Technologies offers a fascinating case study in vertical integration within the medical technology sector. Acquired by the global med-tech giant Getinge in late 2023, the Massachusetts-based company initially built its reputation on advanced organ preservation devices—specialized systems designed to maintain optimal temperatures and monitor organ viability during transit.
However, selling hardware is a fundamentally different business than selling operational capacity. By launching a comprehensive clinical service network, the parent company has transitioned from a traditional medical device manufacturer into an indispensable logistics and service provider. This "procurement-as-a-service" model creates deep, sticky relationships with transplant centers that are virtually impossible to untangle once integrated into daily workflows.
"Transplant programs are being asked to do more every year, and every organ offer comes with a narrow window to act," said Chris Tomosivitch, President of Paragonix Technologies. "We built Transplant Services to plug directly into each program’s existing workflows, from the first call through delivery, so our team operates as part of the transplant team. Supporting UCSF Health through its busiest year is exactly what this work is about, and we’re proud to be a part of it."
This strategic pivot positions the firm uniquely against competitors who remain solely focused on perfusion and preservation hardware. By offering a turnkey solution that includes organ offer coordination, evaluation, surgical recovery, and transport, the company captures a significantly larger share of the value chain while addressing the most acute pain points of hospital administrators.
The Logistics of Life-Saving
The mechanics of third-party organ procurement require an orchestrational precision that rivals military logistics. When a donor heart becomes available, the window of viability—known as cold ischemic time—is notoriously narrow. Every minute an organ spends outside the body increases the risk of primary graft dysfunction and compromises long-term patient survival.
To combat this, third-party recovery networks utilize regional hubs strategically located near major donor pools and transportation arteries. When an offer is accepted by a client hospital, the external service instantly mobilizes a local, highly trained surgical team to the donor hospital. These teams are specifically trained in standardized recovery protocols, ensuring that the organ is extracted, evaluated, and secured in advanced preservation technology with maximum efficiency.
"By standardizing the recovery process through a dedicated third party, hospitals are removing the most unpredictable variable in transplantation—the physical toll on their own staff," noted a healthcare workforce analyst familiar with the model. "It transforms a chaotic, reactive process into a managed logistical pipeline."
This standardization is crucial. In traditional models, the quality and speed of recovery can vary depending on the experience of the dispatched fellow or attending surgeon. Relying on dedicated recovery specialists ensures a consistent, high-quality extraction process, which is fundamental to maintaining optimal graft viability during cross-country transport.
Navigating the Hidden Challenges of Outsourced Procurement
Despite the quantifiable benefits demonstrated by the recent volume records in San Francisco, the outsourced procurement model is not without its hidden challenges. Entrusting a core clinical function to an external entity requires a massive leap of faith for implanting surgeons, who ultimately bear the responsibility for the patient's outcome.
Seamless communication is the linchpin of this model. The external recovery surgeon must provide flawless, real-time evaluations of the donor organ's anatomy and function to the implanting surgeon waiting hundreds of miles away. Any miscommunication regarding the organ's condition or the estimated time of arrival can have catastrophic consequences for the recipient, who is already prepped and waiting in the operating room.
Furthermore, hospital administrators must carefully weigh the economics of this approach. While utilizing a 24/7 on-demand recovery service incurs a premium cost, it must be balanced against the revenue generated by increased transplant volumes. In the case of the recent 31 percent year-over-year growth, the financial arithmetic clearly favors the outsourced model. High-complexity procedures like heart transplants are among the most revenue-intensive services a hospital provides, meaning the return on investment for expanded capacity is substantial.
Regulatory oversight also remains a complex web to navigate. While Organ Procurement Organizations and the Organ Procurement and Transplantation Network heavily regulate the allocation and donation process, the integration of private, third-party surgical networks introduces new layers of compliance and quality assurance. Ensuring that these external teams consistently meet the rigorous standards expected by top-tier academic medical centers requires continuous auditing and transparent data sharing.
Ultimately, the milestone achieved this year serves as a powerful proof of concept for the broader healthcare industry. As the national transplant waiting list continues to lengthen and the demand for life-saving organs consistently outpaces supply, the traditional, self-contained model of transplant surgery is proving inadequate. By embracing operational innovation and leveraging specialized logistical networks, medical centers can transcend their internal limitations, proving that the future of transplant medicine relies just as much on human-centered business strategies as it does on clinical breakthroughs.
Topics & Related
Hospitals & Health Systems
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →